Released on: June 19, 2008, 11:47 pm

Press Release Author: Shushmul Maheshwari

Industry: Pharmaceuticals

Press Release Summary: The E7 pharmaceutical markets are expected to grow at a CAGR
of 11.5% by 2012 due to strong economic growth, improving medical infrastructure and
rising retail pharmacies.

Press Release Body: A new market research report, “Emerging Pharmaceutical
Markets Globally”, recently released by RNCOS says that the pharmaceutical
markets in E7 countries are anticipated to grow at a CAGR of 11.5% from 2008 to
2012. This growth rate is more than double of that in G7 markets.

The report identifies that strong economic growth in E7 countries is one of the main
reasons driving growth in their pharmaceutical markets. The total disposable income
of the E7 countries is anticipated to grow two-fold in 2012 against US$ 4.4 Trillion
in 2007, which will increase the expenditure on healthcare and drugs in the region.

Furthermore, the medical infrastructure has developed tremendously in the E7
countries in the last decade, says the report. As a result, a large number of
clinics and hospitals have opened in these countries. With opening of new clinics
and hospitals, patients are increasingly taking professional advice from physicians
instead of following self-medication and conventional therapies. As the sales of
pharmaceutical sector are directly linked to physician visits, a rise in physician
visits has augmented the sales.

Besides, the report says that an improvement in the medical infrastructure has
directly impacted the smaller towns and villages where majority of E7
countries’ population resides. The volume of retail pharmaceutical stores in
small towns and villages has substantially expanded in the last decade, providing
quality and affordable drugs in these areas.

“Emerging Pharmaceutical Markets Globally” is a comprehensive report
providing data on emerging pharmaceutical markets worldwide. It highlights the
difference between developed and emerging markets in terms of traditional therapies,
health and insurance scenario, and intellectual property, giving critical
information to pharmaceutical companies and investors planning to enter these
markets to help them make strategies according to the E7 markets. The report also
gives forecast on generic drugs and domestic pharmaceutical markets by region and
country.

About RNCOS:

RNCOS, incorporated in the year 2002, is an industry research firm. It has a team of
industry experts who analyze data collected from credible sources. They provide
industry insights and analysis that helps corporations to take timely and accurate
business decision in today\'s globally competitive environment.

For more information visit: http://rncos.com/Report/IM081.htm
Current Industry News: http://www.rncos.com/Blog/

Web Site: http://www.rncos.com

Contact Details: 29, 1st Floor, Patparganj Industrial Area, Delhi 92
91-11-4214-1229
91-11-4214-1228
info@rncos.com

http://www.rncos.com/